Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feldman

Showing results (1041-1050 of 1,068) with videos related to

Pageof 107
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven ApproachLindsey E Roeker, Tatyana A Feldman, Jacob D Soumerai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
JAMA|August 7, 2013
Raccoon rabies virus variant transmission through solid organ transplantationNeil M Vora, Sridhar V Basavaraju, Katherine A Feldman, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Acta Neuropathologica|November 28, 2017
Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau depositionChin Hong Tan, Chun Chieh Fan, Elizabeth C Mormino, et al.
Blood|September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantationJames N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.
The Journal of Pediatrics|December 19, 2013
How are childhood thyroid nodules discovered: opportunities for improving early detectionAnjuli Gupta, Samantha Ly, Luciana A Castroneves, et al.
Cancer|December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United StatesKenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Pageof 107

Showing results (1041-1050 of 1,068) with videos related to

Sort By:
Pageof 107
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven ApproachLindsey E Roeker, Tatyana A Feldman, Jacob D Soumerai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
JAMA|August 7, 2013
Raccoon rabies virus variant transmission through solid organ transplantationNeil M Vora, Sridhar V Basavaraju, Katherine A Feldman, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Acta Neuropathologica|November 28, 2017
Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau depositionChin Hong Tan, Chun Chieh Fan, Elizabeth C Mormino, et al.
Blood|September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantationJames N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.
The Journal of Pediatrics|December 19, 2013
How are childhood thyroid nodules discovered: opportunities for improving early detectionAnjuli Gupta, Samantha Ly, Luciana A Castroneves, et al.
Cancer|December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United StatesKenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Pageof 107